Researchers are calling for more work in to the reasons behind a big increase of young children with Type 1 diabetes. A new study, led by Bristol University, has discovered that the number of children under five-years-old with Type 1 diabetes has increased five-fold over 20 years.
Whilst the largest rise of the condition was seen in children under five, Type 1 diabetes in under 15s almost doubled during the study. There was a 2.3 per cent increase in the number of children diagnosed with Type 1 diabetes each year.
Simon O’Neill, Director of Care, Information and Advocacy Services at Diabetes UK said: “This project has produced some very interesting results.
“The evidence of a steep rise of Type 1 diabetes found in the under fives indicates that the peak age for diagnosis of the condition in the UK is becoming younger. Whilst 10-14 year-olds remain the largest group for diagnosis, the rise in cases found in children under five is worrying.”
Polly Bingley, Professor of Diabetes at Bristol University added: “The incidence of childhood Type 1 diabetes has been shown to be increasing all over Europe, particularly in the very young.
“The increase is too steep to be put down to genetic factors, so it must be due to changes in our environment. This could either mean that we are being exposed to something new, or that we now have reduced exposure to something that was previously controlling our immune responses. We now need to work to identify what these changes might be.”
The new research, to be announced at Diabetes UK’s Annual Professional Conference, comes from researchers at the University of Bristol who were funded by Diabetes UK. The study looked at Oxford’s population of 2.6m people between 1985 and 2004.
Source: Bristol University
Related stories:
Young type-2 diabetic men suffer low testosterone levels, study shows
Young men with type 2 diabetes have significantly low levels of testosterone, endocrinologists at the University at Buffalo have found -- a condition that could have a critical effect on their quality of life and on their ability to father children.
Caesarean babies more likely to develop diabetes
Babies delivered by Caesarean section have a 20 per cent higher risk than normal deliveries of developing the most common type of diabetes in childhood, according to a study led by Queen's University Belfast.
Bone marrow stem cells may help control inflammatory bowel disease
Massachusetts General Hospital (MGH) investigators have found that infusions of a particular bone marrow stem cell appeared to protect gastrointestinal tissue from autoimmune attack in a mouse model. In their report published in the journal
Stem Cells, the team from the MGH Center for Engineering in Medicine report that mesenchymal stem cells (MSCs), known to control several immune system activities, allowed the regeneration of the gastrointestinal lining in mice with a genetic mutation leading to multiorgan autoimmune disease.
New research suggests diabetes transmitted from parents to children
A new study in the September issue of the Journal of Lipid Research suggests an unusual form of inheritance may have a role in the rising rate of diabetes, especially in children and young adults, in the United States.
Blood pressure response to daily stress provides clues for better hypertension treatment
How the body regulates blood pressure in response to daily stress is the focus of a study geared toward helping people whose pressure is out of control.
Scientists create 20 disease-specific stem cell lines
(PhysOrg.com) -- Harvard Stem Cell Institute researcher George Q. Daley, associate director of the Stem Cell Program at Children's Hospital Boston, has with HSCI colleagues Chad Cowan and Konrad Hochedlinger of Massachusetts General Hospital produced a robust new collection of disease-specific stem cell lines, all of which were developed using the new induced pluripotent stem cell (iPS) technique. The work is described in a paper published in today's online edition of the journal
Cell.
2 years old -- a childhood obesity tipping point?
Over the last decade, childhood obesity has grown into an epidemic, reflected in soaring rates of type 2 diabetes and recommendations that pediatricians check toddlers for elevated cholesterol. What hasn't been as clear is how early to intervene.
Treatment corrects severe insulin imbalance in animal studies
Researchers have used a drug to achieve normal levels of blood sugar in animals genetically engineered to have abnormally high insulin levels. If this approach succeeds in humans, it could become an innovative medicine for children with congenital hyperinsulinism, a rare but potentially devastating genetic disease in which insulin levels become dangerously high.